Effector Therapeutics, Inc.
SEC CIK 1828522 · LWAC · last insider filing 2024-06-13
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Ehrlich Christopher B | Director · See Remarks | filed 2021 - 2024 |
| Loewy Caroline M | Director | filed 2021 - 2024 |
| Klencke Barbara | Director | filed 2021 - 2024 |
| Gallagher Brian M. Jr. | Director | filed 2021 - 2024 |
| Bhatt Elizabeth | Director | filed 2021 - 2024 |
| Harrington-Smith Kristen | Director | filed 2022 - 2024 |
| Worland Stephen T | Director · President and Chief Executive | filed 2021 - 2024 |
| Smither John W | Director | filed 2021 - 2023 |
| Root Jonathan D | Director | filed 2021 - 2022 |
| Lasky Laurence | Director | filed 2021 - 2021 |
| Atwood Brian G | Director | filed 2021 - 2021 |
| Kosacz Barbara | Director | filed 2021 - 2021 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Byrnes Michael | Chief Financial Officer | filed 2021 - 2024 |
| Warner Douglas J | Chief Medical Officer | filed 2022 - 2024 |
| Gandhi Mayank | Chief Business Officer | filed 2022 - 2023 |
| Mcnulty Alana B. | Chief Business Officer | filed 2021 - 2022 |
| Patel Premal | Chief Medical Officer | filed 2021 - 2022 |
| Geffken Daniel E. | Chief Financial Officer | filed 2021 - 2021 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.